//
Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial
A randomized multicentre trial to compare revascularization with optimal medical therapy for the treatment of chronic total coronary occlusions
Clinician’s Guide to Reducing Inflammation to Reduce Atherothrombotic Risk
Contemporary Management of Cardiogenic Shock: A Scientific Statement From the American Heart Association
Antithrombotic Therapy after Acute Coronary Syndrome or PCI in Atrial Fibrillation
Cardiopulmonary Exercise Testing: What Is its Value?
Developing and Testing a Personalized, Evidence-Based, Shared Decision-Making Tool for Stent Selection in Percutaneous Coronary Intervention Using a Pre-Post Study Design
Volume brings value